Skip to main content

Solventum Corporation(SOLV-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low67.75
Day High69.03
Open:68.92
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
After a Volatile Run, Here's the Honest Buy, Sell, or Hold on 3M
Tipranks
Piper Sandler Reaffirms Their Buy Rating on Solventum Corporation (SOLV)
Motley Fool
3M vs. United Parcel Service: One of These Industrial Stocks Is a Much Better Buy Right Now
Tipranks
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Solventum Corporation (SOLV) and Shattuck Labs (STTK)
StockStory
3 Reasons to Sell SOLV and 1 Stock to Buy Instead
SOLV
StockStory
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking Solventum (NYSE:SOLV)
SOLV
StockStory
1 Mid-Cap Stock Worth Investigating and 2 That Underwhelm
MTSI
Tipranks
Solventum Corporation (SOLV) Gets a Buy from J.P. Morgan
Tipranks
Analysts Conflicted on These Healthcare Names: TG Therapeutics (TGTX), Insmed (INSM) and Solventum Corporation (SOLV)
Motley Fool
This Medical Device Stock Has Compounded at 13% Per Year for a Decade
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
StockStory
1 Profitable Stock with Exciting Potential and 2 We Question
FTDR
Tipranks
Solventum Announces Planned Retirement of Chief Accounting Officer
StockStory
Why Solventum (SOLV) Shares Are Sliding Today
SOLV
Zacks Investment Research
Here's Why You Should Hold Solventum Stock in Your Portfolio Now
Here's Why You Should Hold Solventum Stock in Your Portfolio Now
Tipranks
Piper Sandler Keeps Their Buy Rating on Solventum Corporation (SOLV)
StockStory
1 Healthcare Stock with Exciting Potential and 2 We Ignore
SOLV
StockStory
3 of Wall Street’s Favorite Stocks with Open Questions
ZM
Motley Fool
Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue
Motley Fool
Thermon Stock Up 60% as Investor Builds $16 Million Position in the Industrial Heating Firm
Stock Target Advisor
Stagflation Fears Emerge-Market Analysis for March 9th, 2026
Investors Balance Risk-Market Analysis for March 9th, 2026
Tipranks
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV)
Tipranks
UBS Reaffirms Their Hold Rating on Solventum Corporation (SOLV)
Tipranks
Solventum Earnings Call Balances Growth With Headwinds
Tipranks
Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks
Tipranks
Solventum Corporation (SOLV) Receives a Buy from Stifel Nicolaus
Tipranks
BTIG Reaffirms Their Buy Rating on Solventum Corporation (SOLV)
Tipranks
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Solventum Corporation (SOLV) and Privia Health Group (PRVA)
StockStory
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
CLOV
Zacks Investment Research
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Motley Fool
Solventum (SOLV) Q4 2025 Earnings Call Transcript
StockStory
Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates
SOLV

Profile

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.